Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
uGDMT in Heart Failure
NCT07781826Phase 1Completed
- Sponsor
- Wroclaw Medical University
- Start
- Mar 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, randomised trial of finerenone in heart failure (HF) (2 arms), sponsored by Wroclaw Medical University. Primary endpoints: Change in pre-diuretic sodium avidity at 2 weeks and Change in post-diuretic sodium avidity at 2 weeks. Started Mar 2024; status: completed.
02
Drugs
finerenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07781826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07781826.